Whitehouse Station, NJ - Chubb has expanded its global clinical trial liability insurance coverage for institutional research organizations such as hospitals and medical centers, universities and colleges, research institutes, patient/disease advocacy organizations and physician practices, which represent a growing sector of organizations facing risks associated with managing clinical trials. Historically, Chubb has provided clinical trial coverage for institutional research organizations through its Healthcare Industry Practice. As these nontraditional research organizations have expanded, comprehensive standalone clinical trial insurance for their domestic and foreign clinical trials can be secured through Chubb's dedicated Life Sciences Industry Practice, which provides specialized insurance and risk management solutions including products liability coverage exclusively to this industry.
"Traditional life sciences organizations such as pharmaceutical, biotechnology and medical device firms are not the only organizations exposed to clinical trial risks. Institutional research organizations are exposed to many of the same risks, including significant product liability claims, as well as problems related to inadequate insurance coverage, all of which can lead to trial delays and costly setbacks," said Stephen Harris, Senior Vice President, Chubb Life Sciences. "At Chubb, we recognize the world of clinical trials is evolving. To continue meeting our customers' needs, we have expanded the availability of our clinical trial products and services to help non-commercial enterprises manage the complex risks that come with trial activities."
Chubb Clinical Trial products and services include:
For more than 25 years, Chubb has been a leader in offering state-of-the-art property and casualty insurance protection to life sciences companies, and agents and brokers can access the Life Sciences Industry Practice throughout Chubb's 48 North American branches. Visit chubb.com to learn more.
About Chubb
Chubb is the world's largest publicly traded property and casualty insurance company. With operations in 54 countries, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. As an underwriting company, we assess, assume and manage risk with insight and discipline. We service and pay our claims fairly and promptly. The company is also defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (CB) and is a component of the S&P 500 index. Chubb maintains executive offices in Zurich, New York, London and other locations, and employs approximately 31,000 people worldwide. Additional information can be found at chubb.com.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.